Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,942 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications.
Bhatt A, Bakrin N, Kammar P, Mehta S, Sinukumar S, Parikh L, Shaikh S, Mishra S, Mallaya M, Kepenekian V, Benzerdjeb N, Glehen O. Bhatt A, et al. Among authors: mehta s. Eur J Surg Oncol. 2021 Jan;47(1):181-187. doi: 10.1016/j.ejso.2020.10.012. Epub 2020 Oct 14. Eur J Surg Oncol. 2021. PMID: 33071172
A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer - A study by INDEPSO.
Sinukumar S, Rajan F, Mehta S, Damodaran D, Zaveri S, Kammar P, Bhatt A. Sinukumar S, et al. Among authors: mehta s. Eur J Surg Oncol. 2021 Jan;47(1):75-81. doi: 10.1016/j.ejso.2019.02.031. Epub 2019 Feb 23. Eur J Surg Oncol. 2021. PMID: 30857879
Total parietal peritonectomy performed during interval cytoreductive surgery for advanced epithelial serous ovarian cancer results in a low incidence of platinum resistant recurrence- results of a prospective multi-centre study.
Bhatt A, Sinukumar S, Parikh L, Mehta S, Shaikh S, Jumle N, Kammar P. Bhatt A, et al. Among authors: mehta s. Eur J Surg Oncol. 2021 Aug;47(8):2150-2157. doi: 10.1016/j.ejso.2021.04.003. Epub 2021 Apr 14. Eur J Surg Oncol. 2021. PMID: 33875284
Greater-omentum lesion-score (GOLS) as a predictor of residual disease in different regions of the peritoneal cavity in patients undergoing interval cytoreductive surgery for advanced ovarian cancer and its potential clinical utility.
Bhatt A, Kammar P, Rousset P, Sinukumar S, Mehta S, Parkih L, Goswami G, Shaikh S, Kepenkian V, Bakrin N, Devouassoux-Shisheboran M, Glehen O. Bhatt A, et al. Among authors: mehta s. Eur J Surg Oncol. 2021 Nov;47(11):2925-2932. doi: 10.1016/j.ejso.2021.05.028. Epub 2021 May 18. Eur J Surg Oncol. 2021. PMID: 34030922
Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO).
Bhatt A, Sinukumar S, Mehta S, Damodaran D, Zaveri S, Kammar P, Mishra S, Parikh L, Ranade R, Penumadu P, Rajan F. Bhatt A, et al. Among authors: mehta s. Eur J Surg Oncol. 2019 Apr;45(4):666-671. doi: 10.1016/j.ejso.2019.01.009. Epub 2019 Jan 9. Eur J Surg Oncol. 2019. PMID: 30661922
6,942 results